Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide☆
Background/Purpose: Switching to a tenofovir alafenamide (TAF)-containing regimen has been reported to be associated with body weight gain in human immunodeficiency virus-infected subjects. We aimed to investigate the body weight change and virological, hepatic, and renal outcomes of TAF switching a...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2022-07-01
|
| Colecção: | Journal of the Formosan Medical Association |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S0929664621004319 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|